DNA vaccines for non-infectious diseases: new treatments for tumour and allergy (Q35164804)

6 August 2017

1 reference

title

DNA vaccines for non-infectious diseases: new treatments for tumour and allergy (English)

1 reference

6 August 2017

Wolfgang W Leitner

1

1 reference

6 August 2017

Josef Thalhamer

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Expert Opinion on Biological Therapy

6 August 2017

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

627-638

1 reference

Heterologous protection against influenza by injection of DNA encoding a viral protein

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Genetic immunization is a simple method for eliciting an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

DNA vaccines: immunology, application, and optimization*

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

DNA and RNA-based vaccines: principles, progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Nucleic acid for the treatment of cancer: genetic vaccines and DNA adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Potential DNA vaccine integration into host cell genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

DNA vaccines for emerging infectious diseases: what if?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Ubiquitin-fused and/or multiple early genes from cottontail rabbit papillomavirus as DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Cancer therapy using a self-replicating RNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Immunotherapy of cancer with dendritic-cell-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Building better vaccines: how apoptotic cell death can induce inflammation and activate innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Alphavirus vectors: development and potential therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Cancer immunotherapy using Sindbis virus replicon particles encoding a VP22-antigen fusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Particle-mediated nucleic acid immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Induction of cytotoxic T-cell responses by gene gun DNA vaccination with minigenes encoding influenza A virus HA and NP CTL-epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

The cutaneous citadel: a holistic view of skin and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Microfabricated microneedles for gene and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

In vivo DNA electrotransfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Application of in vivo electroporation to cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Intramuscular electroporation delivery of IFN-alpha gene therapy for inhibition of tumor growth located at a distant site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Induction of immune responses by DNA vaccines in large animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Receptors and cytokines involved in allergic TH2 cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Absence of immunoglobulin E synthesis and airway eosinophilia by vaccination with plasmid DNA encoding ProDer p 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Expression and immunogenicity of the major house dust mite allergen Der p 1 following DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

The effect of vaccination with DNA encoding murine T-cell epitopes on the Der p 1 and 2 induced immunoglobulin E synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Efficacy of recombinant adenovirus as vector for allergen gene therapy in a mouse model of type I allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Antigen-independent suppression of the allergic immune response to bee venom phospholipase A(2) by DNA vaccination in CBA/J mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

High-level expression in mammalian cells of recombinant house dust mite allergen ProDer p 1 with optimized codon usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Codon usage tabulated from international DNA sequence databases: status for the year 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Risk factors for classical Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

Super-activated interferon-regulatory factors can enhance plasmid immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.627

21 January 2018

Identifiers

DOI

10.1517/14712598.3.4.627

1 reference

6 August 2017

1 reference